SCHEMBL8502011

SCHEMBL8502011

CC(C)CN(NCc1ccccc1)C(=O)N(C[C@H](O)CCc1ccccc1)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
ALDH1A1 P00352 2/20 0.39
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HTT P42858 2/20 0.39
TSHR P16473 1/20 0.38
LMNA P02545 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.36
MAPT P10636 1/20 0.35
MMP8 P22894 1/20 0.35
DPP4 P27487 1/20 0.35
KCNA5 P22460 1/20 0.35
MMP2 P08253 1/20 0.34
MMP9 P14780 1/20 0.34
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
MMP14 P50281 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8501207 0.83 AKT1 (0.47) KMT2AMEN1L3MBTL1HTTKCNA5
SCHEMBL8502297 0.81 AOC3 (0.43) SMN1; SMN2KMT2AMEN1L3MBTL1HTT
Hydrochloric Acid SCHEMBL8505045 0.81 AOC3 (0.42) SMN1; SMN2KMT2AMEN1L3MBTL1HTT
SCHEMBL8648237 0.79 AOC3 (0.43) SMN1; SMN2KMT2AMEN1L3MBTL1HTT
SCHEMBL8504370 0.78 AOC3 (0.42) SMN1; SMN2KMT2AMEN1L3MBTL1HTT
SCHEMBL1529633 0.78 KMT2A (0.54) SMN1; SMN2ALDH1A1KMT2AMEN1L3MBTL1
SCHEMBL8502790 0.76 MEN1 (0.44) ALDH1A1KMT2AMEN1L3MBTL1HTT
SCHEMBL7776615 0.70 MMP8 (0.38) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR
SCHEMBL8505244 0.70 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1KMT2AMEN1L3MBTL1
SCHEMBL10076985 0.69 TSHR (0.51) SMN1; SMN2ALDH1A1KMT2AMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5872298-A Method of preparing intermediates for retroviral protease inhibitors G. D. SEARLE & CO. (US) 1999-02-16 US disclosed
US-5872299-A Method of preparing intermediates for retroviral protease inhibitors G. D. SEARLE & CO. (US) 1999-02-16 US disclosed
US-5831117-A ACID SALTS G. D. SEARLE & CO. (US) 1998-11-03 US disclosed